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osting by EAbstract Background: Scorpion envenomation is common among desert dwellers, affecting sev-
eral systems and resulting in multiple organ dysfunction (MOD) or failure (MOF), mainly due
to their action on Na+ channels. Although scorpion venoms toxins do not pass the blood brain bar-
rier, their CNS effects are prominent, occurring in conjunction with, or as an aftermath of periph-
eral actions of the venom.
Objective: To determine the ability of venom of the common scorpion Leiurus quinquestriatus
(LQQ) to induce MOD or MOF when injected into rabbits in micro quantities centrally (intracere-
broventricularly, i.c.v.) or macro amounts peripherally (s.c. or i.v.). Also, to assess if the Na+ chan-
nel blocker lidocaine can protect rabbits from the resultant manifestations.
Methods: Rabbits were injected with LQQ venom centrally or peripherally, in either sublethal or
lethal doses, and MOD or MOF determined by assessing: cardiac output (CO), estimated hepatic
blood ﬂow (EHBF), biochemical parameters indicative of cardiac/hepatic/renal and pancreatic
functions, blood pressure (BP), survival, lung/body index (LBI, indicative of pulmonary edema),
and/or histological changes in hearts, lungs, livers plus kidneys. In pre-treatment experiments,
lidocaine was injected 40 min before venom and protective ability examined.y, College of Pharmacy, King
11421, Saudi Arabia.
ity. All rights reserved. Peer-
d University.
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138 A.J. FataniResults: LQQ venom in sublethal doses caused comparable signiﬁcant reductions (vs control) in
CO and EHBF when injected i.c.v. (2 lg kg1) or s.c. (0.2 mg kg1). Both routes caused
gradual dose-related enhanced levels of creatine kinase, lactate dehydrogenase, aspartate amino-
transferase, alanine aminotransferase, creatinine, glucose and amylase, indicating MOD. Also, char-
acteristic venom-induced changes in BP were evident after lethal doses of venom i.v. (0.5 mg kg1) or
i.c.v. (3 lg kg1). Histological changes in the organs plus LBI were comparable after i.c.v. and i.v.
venom injection, with animals ultimately exhibiting MOF. Lidocaine (1 mg kg1 i.v., then infusion
50 lg kg1 min1, 30 min before venom), protected the animals fromMOF evoked by lethal doses of
the venom (whether injected centrally or peripherally), as evidenced by the amelioration of the
venom’s effects on blood pressure, LBI, survival and multiple organ histopathological manifesta-
tions.
Conclusion: LQQ venom, whether injected centrally or peripherally caused comparable systemic
dose-dependent MOD or MOF, with the latter attenuated by the Na+ channel blocker lidocaine,
indicating a role for Na+ channels.
ª 2010 King Saud University. All rights reserved.1. Introduction
Scorpion envenomation is a major public health issue in many
countries, including the Middle plus Far East, Africa and
South America (Al-Sadoon and Jarrar, 2003; De Roodt
et al., 2003; Patil, 2009).
Severity of scorpion envenomation symptoms, in humans
or animals, varies according to scorpion type, sting site, age,
weight, and health status. It usually starts with local pain at
sting site, and may progress to serious dysfunctions in the car-
diac, respiratory, gastrointestinal, pancreatic, immunological,
peripheral and central nervous systems, leading in severe cases
to multi-organ failure (MOF) and death. Elderly and especially
children usually exhibit increased severity of peripheral and
central manifestations (Osnaya-Romero et al., 2001; Pipel-
zadeh et al., 2007; Bosnak et al., 2009).
From 1500 species of scorpions described only a few are of
medical importance, with the yellow scorpion Leiurus quinque-
striatus (LQQ) and Androctonus crassicauda being the most
common in the Middle East (Al-Asmari et al., 2007). Toxic
manifestations of scorpion venom toxins are due to their abil-
ity to act mainly on Na+ and to a lesser degree K+ and Ca2+
channels, prolonging depolarization, causing massive release
of neurotransmitters and modulators and thus affecting differ-
ent systems. Treatment with channel blockers have been shown
to protect animals from systemic pathological manifestations
and lethality of animals injected peripherally with LQQ scor-
pion venom (Fatani et al., 2000, 2010; Vital et al., 2002;
Al-Shanawani et al., 2005).
Despite the fact that neurological effects such as agitation,
brain infarcts and convulsions, have been observed after scor-
pion envenoming (Mesquita et al., 2003; Bahloul et al., 2005;
Boyer et al., 2009; Nencioni et al., 2009), action on the central
nervous system (CNS) was originally excluded, since peptides
do not cross the blood–brain barrier (Revelo et al., 1996). Neu-
rological manifestations were explained at least in part,
through the action of the venom toxins on the peripheral ner-
vous system (Ismail, 1995). However, Clot-Faybesse et al.
(2000) and Nunan et al. (2003) reported ﬁnding scorpion tox-
ins in the CNS after systemic injection in newborn mice, with a
not fully developed blood–brain barrier. Moreover, following
the peripheral inoculation of venom or toxins from the Tityusspecies, Nencioni et al. (2009) postulated a central mechanism
for systemic manifestations and Guidine et al. (2009) suggested
the involvement of the brainstem associated with cardiovascu-
lar control.
On the other hand, several investigators have injected
Tityus serrulatus venom or its toxins centrally and shown
induction of epileptiform wave discharges, convulsions, ictal
behaviour, and suggested systemic cardiorespiratory involve-
ment (Sandoval and Dorce, 1993; Carvalho et al., 1998; Mesq-
uita et al., 2003). The relationship between venom-elicited
effects following either central or peripheral injection of scor-
pion venoms requires further investigation, especially with ve-
nom from Old World Scorpions common in the Middle East,
where few studies have been performed. Moreover, it needs to
be assessed whether the Na+ channel blocker, lidocaine, is as
effective against centrally-injected venom as it is against venom
inoculated peripherally (Fatani et al., 2000, 2010; Al-Shanawani
et al., 2005).
Therefore, this study endeavoured to examine the effects of
one of the more toxic venoms found in abundance in Saudi
Arabia, the a neurotoxic venom from the Old World scorpion
LQQ. Systemic manifestations following peripheral injection
of macro amounts were compared to that of micro quantities
(100 times less) injected centrally. Moreover, multiple organ
dysfunction, MOD, seen with sublethal doses of venom was
compared with multiple organ failure, MOF, observed after
injection of lethal doses. Finally, this study examined whether
the Na+ channel blocker lidocaine would be effective in pro-
tecting rabbits from MOF observed after central injection of
lethal doses of the venom.
2. Material and methods
2.1. Scorpion venom, chemicals and drugs
Venom from L. quinquestriatus quinquestriatus (LQQ) scorpi-
ons were collected, milked and lyophilized by The Antivenom
Center at King Abdul Aziz National Guard Medical Complex,
Riyadh, Saudi Arabia. Lyophilized venom was kept at 20 C
and reconstituted by 0.9% NaCl (1 mg ml1) when required.
All other drugs and chemicals used were of analytical grade
and supplied by Sigma (UK).
Comparative study between peripherally and centrally acting sublethal and lethal 1392.2. Animals
New Zealand white male rabbits (2.8–3.5 kg) were obtained
from the Animal Care Center, College of Pharmacy, King
Saud University (KSU). They were housed at 24 ± 1 C under
a 12:12 light–dark cycle with free access to food and water up
to 24 h before the experiment, where they were fasted from
food. All efforts were made in order to avoid any unnecessary
suffering to the animals. Experiments were carried out in
accordance with national and international ethical guidelines,0
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Figure 1 Effect of subcutaneous (0.2 mg kg1) or intracerebroventric
vs time curves of ICG dye (4 mg kg1, i.v), utilized to determine cardia
are mean ± SEM of ﬁve rabbits.and approval of the care and use of laboratory animals Ethical
Committee at King Saud University.
2.3. Preparation of animals
Rabbits were heparinized (1000 IU Kg1, i.v.). For i.c.v. injec-
tions, animals were anaesthetised with diethyl ether, put on a
warmed operating table (37) under aseptic conditions and posi-
tioned in a stereotaxic frame. Amodiﬁed shortened tip of a 10 ll
microsyringe (Hamilton Company, Reno, NV, USA) wasy = -33.741Ln(x) + 101.42
R2 = 0.9672
y = -38.434Ln(x) + 119.33
R2 = 0.9369
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140 A.J. Fataniinserted into the right lateral ventricle (Paxinos and Watson,
1998), and lightly fastened to skull bone with dental acrylate.
Animalswere left for 5–10 min to recover fromanaesthesia prior
to slow i.c.v. injection of 0.9%NaCl (2 ll) or LQQ venom (2 or
3 lg kg1), after which the needle was pulled out and insertion
location sealed with dental acrylate. The i.v. administered
drugs/venom were introduced via the marginal ear vein and
blood samples extracted from the central ear artery via heparin-
ized 20 gauge cannulas. In some experiments venomwas injected
s.c. to mimic natural envenomation, while in others it was in-
jected i.v. and i.c.v. to observe central and peripheral effects,
without the added factors of absorption. Conscious rabbits were
utilized since dynamic measurements were required and would
be affected by anaesthesia and ﬁve rabbits were used for each
experiment. Surviving animals at the end of the 300 min time-
limit were killed by an overdose of diethyl ether.
2.4. Determination of cardiac output and estimated hepatic blood
ﬂow in rabbits following s.c. and i.c.v. LQQ venom injection
Cardiac output (CO) and estimated hepatic blood ﬂow
(EHBF) were determined using the fast and reproducible indi-
cator dilution technique based on Fick’s principle, with contin-
uous non invasive measurement of indocyanine green (ICG)
dye plasma concentration (Henschen et al., 1993). Rabbits (4
groups/5 each) were injected with either 0.9 % NaCl (control,
0.2 ml kg1, s.c. or 2 ll kg1, i.c.v.) or sublethal doses of ve-
nom (0.2 mg kg1, s.c. or 2 lg kg1, i.c.v.), 10 min after ICG
injection (4 mg kg1, i.v). A dose below the iv LD50 of LQQ
venom (0.25 mg kg1) (Fatani, 1990) was selected, and equiv-
alent i.c.v. dose, determined in pilot experiments, that exhib-
ited venom-evoked alterations but allowed survival of all
rabbits (data not shown).
For CO, following dye injection, arterial blood samples
(0.3 ml) were collected every 3 s for 40–50 s. Extrapolation of
disappearance curve was done to separate once appearing
dye from recirculating dye.The COwas calculated ðLmin1Þ
¼ amount of ICG injected ðmgÞ60
concentration ðmgL1Þ during first circulationextrapolated time ðsÞ of the primary curveEstimated hepatic blood ﬂow (EHBF) was measured by a
method superior to static tests, more sensitive than serum en-
zymes for assessing liver dysfunction (Sakka, 2007). BloodTable 1 Cardiac output and estimated hepatic blood ﬂow fol
(2 lg kg1) injection of LQQ venom in adult male rabbits.
Item Subcutaneous Injection
0.9% NaCl
Weight (kg) 3.8 ± 0.3
ICG dose (mg) 15.1 ± 1.1
Cardiac output (ml min1 kg1) 182 ± 10.8
EHBF (ml min1 kg1) 5.82 ± 0.7
Values are mean ± SEM of ﬁve rabbits.
* P< 0.05: compare to corresponding control group.
** P< 0.01: compare to corresponding control group.samples (0.3–0.5 ml) were collected from the same animals at
0, 2, 5, 7, 10, 15 and 30 min after dye injection and EHBF
calculated from the Semi-logarithmic plasma clearance of
ICG according to the following equation:
EHBF ¼ 0:693
 blood volume ðBVÞ=elimination half life ðT1=2Þ
where blood volume = amount of ICG injected (mg)/zero
time intercept.
In both cases, ICG absorbance was determined spectropho-
tometrically at 795 nm and concentration calculated from ICG
standard calibration curve. After the 20 min sample, animals
were allowed to drink freely, in an attempt to partly replenish
lost ﬂuid, prior to the initiation of the next portion of the
experiment.2.5. Measurement of selected biochemical parameters indicative
of organ dysfunction in rabbits following s.c. and i.c.v. LQQ
venom injection
Following the previous experiment, blood samples (1.5–2 ml)
for biochemical analysis were extracted at 0, 1, 3 and 6 h from
the heparinized cannulas inserted into the central ear artery
from the control and venom-treated animals (doses mentioned
in the previous section). In an attempt to compare the effects
of sublethal (organ dysfunction, MOD) and lethal doses (or-
gan failure, MOF, prior to death) of venom, another group
of rabbits were injected i.c.v. with a lethal dose (3 lg kg1)
as determined by the pilot experiments (data not shown) to
have equivalent biochemical effects to that of the s.c. minimum
lethal dose (0.5 mg kg1 = 2 LD50) (Fatani, 1990; Abdoon
and Fatani, 2009).
Biochemical parameters including those indicative of car-
diac, hepatic, kidney and pancreatic functions were determined
(Hitachi 917 machine, Boehringer Mannheim, Germany): cre-
atine kinase, CKMB, lactate dehydrogenase, LDH, aspartate
aminotransferase, AST, alanine aminotransferase, ALT, creat-
inine, Cr, blood urea nitrogen, BUN, glucose and amylase
(Titz, 1995). In the previous experiments, the accepted volume
of blood extracted (Kron et al., 1991) from New Zealand rab-
bits (2.8–3.5 kg) were not exceeded (with replenishment: 7.5–
10% total blood volume, 6% of body weight @ 56 ml kg1 in
rabbits) and hematocrit levels at the end of the experiment
were within normal range.lowing subcutaneous (0.2 mg kg1) or intracerebroventricular
Intracerebroventricular Injection
LQQ venom 0.9% NaCl LQQ venom
3.9 ± 0.3 3.7 ± 0.15 3.8 ± 0.14
15.5 ± 1.1 14.9 ± 0.6 15 ± 0.6
126 ± 4.9** 191 ± 10.2 133 ± 7.6**
3.74 ± 0.13* 7.1 ± 0.53 2.97 ± 0.31**
Comparative study between peripherally and centrally acting sublethal and lethal 1412.6. Blood pressure measurements following i.v. and i.c.v. venom
injection alone or after pretreatment with lidocaine
In another set of experiments, rabbits were prepared for i.c.v.
or i.v. injections as mentioned earlier. Arterial blood pressure
(BP) was recorded via heparinized polyethylene tubes inserted0
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Figure 2 Effect of subcutaneous (0.2 mg kg1) or intracerebroventric
phosphokinase (CK) and lactate dehydrogenase (LDH) levels (U L1)
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Figure 3 Effect of subcutaneous (0.2 mg kg1) or intracerebroventricular (2 and 3 lg kg1) injections of LQQ venom on serum aspartate
(AST) and alanine aminotransferase (ALT) levels (U L1) in adult male rabbits. Bars represent mean ± SEM of ﬁve rabbits. *P< 0.05,
**P< 0.1, ***P< 0.001: compared to corresponding control group; +P< 0.05: compared to corresponding group injected s.c.
142 A.J. Fataniments, venom was injected 30 min after lidocaine (1 mg kg1,
i.v. initially, then i.v. infusion of 50 lg kg1 min1, at a rate
of 4.5 ml h1). Rabbits were left to stabilize for 20 min before
experiments. Lethal doses of the venom were administered
i.v. to enable proper assessment of protective ability of lido-
caine against lethality and MOF especially cardiorespiratory
manifestations.2.7. Assessment of pathological manifestation, lung body weight
index and lethality following central and peripheral venom
injection alone or after pre-treatment with lidocaine
In all rabbits utilized in the previous experiments and injected
with either 0.9% NaCl or sublethal/lethal doses of LQQ ve-
nom (s.c., i.v. or i.c.v.), in addition to rabbits pre-treated with
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Figure 4 Effect of subcutaneous (0.2 mg kg1) or intracerebroventricular (2 and 3 lg kg1) injections of LQQ venom on serum BUN
and creatinine concentrations (mmol L1) in adult male rabbits. Bars represent mean ± SEM of ﬁve rabbits. *P< 0.05, **P< 0.01:
compared to corresponding control group. Bars represent mean ± SEM of ﬁve rabbits. *P< 0.05, **P< 0.01: compared to
corresponding control group.
Comparative study between peripherally and centrally acting sublethal and lethal 143lidocaine, the following was assessed: (a) survival at the end of
the 300 min experiment time limit, (b) lung weight/body weight
index, indicative of pulmonary edema, and (c) light micro-
scopic examination of hearts, lungs, kidneys and livers (ﬁxedin 10% formalin, stained with Hematoxylin and Eosin (H
and E) stain). In the latter, average of changes in all animals
in group were marked according to the following scale: (),
No degenerative change; (+), mild degenerative changes;
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Figure 5 Effect of subcutaneous (0.2 mg kg1) or ntracerebroventricular (2 and 3 lg kg1) injections of LQQ venom on serum glucose
and amylase concentrations (U L1) in adult male rabbits. Bars represent mean ± SEM of ﬁve rabbits. *P< 0.05, **P< 0.01: compared
to corresponding control group.
144 A.J. Fatani(++), moderate degenerative changes; and (+++), marked
degenerative changes. Histopathological studies were per-
formed by someone blind to treatment.
2.8. Statistical analysis
Results were expressed as arithmetic mean ± SEM of ﬁve rab-
bits. Statistical signiﬁcance was evaluated by Kruskal–Wallis
non-parametric analysis of variance and Dunn’s multiple com-
parisons post test, with P 6 0.05 considered signiﬁcant. Instatstatistical program was used to perform the analysis. Survival
was analysed utilizing Wilcoxon survival statistics.
3. Results
3.1. Determination of cardiac output and estimated hepatic blood
ﬂow in rabbits following s.c. and i.c.v. LQQ venom injection
Injection of sublethal doses of venom, s.c. or i.c.v., shifted to
the right the extrapolated disappearance curve, indicative of
Comparative study between peripherally and centrally acting sublethal and lethal 145CO (Fig. 1A and B), with the response from the latter route
being signiﬁcantly more rapid and reaching higher concentra-
tions than with the s.c (P< 0.05). Plasma disappearance curves
of ICG dye of conscious rabbits, indicative of EHBF, were also
shifted to the right after s.c. or i.c.v. venom injections. Addi-
tionally, LQQ venom, regardless of route signiﬁcantly reduced
CO and EHBF when compared to control groups (Table 1).
3.2. Measurement of selected biochemical parameters indicative
of organ dysfunction/ failure in rabbits following s.c. and i.c.v.
LQQ venom injection
Injection of sublethal doses of venom whether s.c. or i.c.v. led
to several biochemical changes, with animals alive 24 h later.140 
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occasionally increased to 5 mm s1. Ach: acetylcholine (0.5 lg kg1, ivWhen a lethal dose was injected i.c.v., animals died approxi-
mately after 1 h. Biochemical changes after lethal doses of ve-
nom were injected s.c. were previously reported (Fatani, 1990;
Abdoon and Fatani, 2009) and were qualitatively similar to
that seen in this study after i.c.v. injection.
3.2.1. Effect of s.c. and i.c.v. LQQ venom injection on serum
CKMB and LDH in rabbits
Injection of LQQ venom s.c. or i.c.v. caused gradual increases
in serum CKMB and LDH. Values started to be signiﬁcant 1 hr
(lethal i.c.v. dose) or 3 h (sublethal i.c.v. and s.c. doses) and on-
wards, as compared to time-matched control values. Values
were signiﬁcantly higher in animals injected with venom i.c.v.
vs s.c. in LDH group at 6 h (Fig. 2).300 min 
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146 A.J. Fatani3.2.2. Effect of s.c. and i.c.v. LQQ venom injection on serum
AST and ALT in rabbits
Injection of venom s.c or i.c.v lead to a time-dependent rise in
serum AST and ALT levels that became signiﬁcant (vs control
group) between 1 and 3 h after venom injection and onwards.
Moreover, values were signiﬁcantly higher in animals injected
with venom i.c.v. than in those injected s.c, at 6 h in AST
group (Fig. 3).
3.2.3. Effect of s.c. and i.c.v. venom injection on serum BUN and
creatinine in rabbits
Serum BUN, showed a gradual increase that became signiﬁ-
cant 6 h after injection of a sublethal dose of venom i.c.v. Sim-
ilarly, creatinine exhibited a signiﬁcant rise prior to death of
animals injected with lethal doses of the venom i.c.v or after
6 h when sublethal doses were injected s.c or i.c.v (Fig. 4).
3.2.4. Effect of s.c. and i.c.v. venom injection on serum glucose
and amylase in rabbits
As seen in Fig. 5A and B venom caused a signiﬁcant rise in ser-
um glucose level 1 h after s.c. or i.c.v. injection of sublethal or
lethal doses of venom. Glucose levels remained signiﬁcantly
elevated up to 6 hrs after i.c.v injection of the sublethal dose
of venom.
Injection of sublethal doses of LQQ venom s.c. or i.c.v.
caused a gradual signiﬁcant increase in serum amylase from
3 h and onwards. Amylase was also signiﬁcantly elevated prior
to death of animals injected with lethal doses of the venom
i.c.v. (Fig. 5C and D).
3.3. Effect of pretreatment with lidocaine on venom-evoked
changes in arterial blood pressure of rabbits
LQQ venom was administered i.v. (to eliminate the added fac-
tor of absorption) in a dose (0.5 mg kg1) that killed rabbits inLid iv 
Infusion 
40 min 
LQQ 
3 µg kg-1
ICV 
15 min 30 min
75 min 90 min 120 min
min
70 
140 
70 
140 
mm Hg 
Figure 7 Representative trace depicting the typical changes in arteri
(1 mg kg1, i.v., then i.v. infusion of 50 g kg1 min1), 30 min before
(3 g kg1). Speed of recording = 0.25 mm s1.about one hr to allow time for assessment of treatment. An
equivalent dose (from pilot studies) was injected i.c.v.
(3 lg kg1) Fig. 6. As seen in the typical representative traces
in Fig. 7B and C, LQQ venom usually causes a triphasic effect:
an initial transient reduction, followed by a prolonged gradual
increase in ABP and a gradual terminal hypotensive phase that
ended with death at 70 ± 8.2 and 55 ± 6.3 min, with i.v. and
i.c.v. routes, respectively (Table 2)
As seen in the representative trace (Fig. 7), lidocaine
(1 mg kg1, iv bolus, then iv infusion of 50 lg kg1 min1,
30 min before venom) did not affect the initial decline or sub-
sequent rise in BP of animals injected with LQQ venom i.c.v.
However, it protected the animals from the terminal hypoten-
sion and greatly prolonged survival (Table 2) with all rabbits
alive at the end of the experiment time limit. Similar results
were previously reported when animals were injected with ve-
nom i.v. (Fatani et al., 2000).
3.4. Effect of Pretreatment with Lidocaine on venom-evoked
changes in lung/ body weight index of rabbits
Injection of lethal doses of LQQ venom whether i.v (0.5 mg
kg1) or (i.c.v, 3 lg kg1) produced a signiﬁcant (P< 0.05
vs all saline-treated groups) increase in lung body weight in-
dex, indicative of pulmonary edema (Table 2).
Pretreatment of animals with lidocaine iv signiﬁcantly pro-
tected the rabbits from the icv venom-evoked enhanced lung/
body weight index (P< 0.05) (Table 2).
3.5. Effect of pretreatment with lidocaine on venom-evoked
histopathological changes indicative of multiple organ
dysfunction in rabbits
In contrast to rabbits (n= 5) injected with 0.9% NaCl (s.c, i.v
or i.c.v) where there were no remarkable changes (Fig. 8A, C,min
45 min 60 min
150 min 180 min 210 min 270 min 300 min
300 min
al blood pressure following pretreatment of rabbits with lidocaine
intracerebroventricular injection of a lethal dose of LQQ venom
Table 2 Lung body weight index and survival time of male adult rabbits injected with LQQ scorpion venom by different routes alone
or 30 min after pretreatment with lidocaine.
Treatment Lung body weight
index (mean ± SEM)
Survival time (min) at end of 300 min
time-limit (mean ± SEM)
0.9% NaCl, s.c.
0.2 ml kg1
0.27 ± 0.011 300 ± 0.0
0.9% NaCl, i.c.v.
2 ll kg1
0.28 ± 0.016 300 ± 0.0
LQQ, s.c.
0.2 mg kg1
0.36 ± 0.019 300 ± 0.0
LQQ, i.v.
0.5 mg kg1
0.44 ± 0.022* 70 ± 8.2*
LQQ, i.c.v.
2 lg kg1
0.38 ± 0.026 300 ± 0.0
LQQ, i.c.v.
3 lg kg1
0.46 ± 0.025* 55 ± 6.3**
Lidocaine, i.v. + LQQ, i.c.v.
3 lg kg1
0.32 ± 022*** 300 ± 0.0****
Lidocaine, i.v. + LQQ, i.v.
0.5 mg kg1
0.33 ± 016*** 300 ± 0.0****
Values are mean ± SEM of ﬁve rabbits.
* P< 0.05: compared to corresponding control group.
** P< 0.01: compared to corresponding control group.
*** P< 0.05: compared to animals treated with lethal doses of venom i.v. or i.c.v.
**** P< 0.0l: compared to animals treated with lethal doses of venom i.v. or i.c.v.
Comparative study between peripherally and centrally acting sublethal and lethal 147E and G), microscopical examination of various organs of rab-
bits (each group n= 5) excised from animals injected with
sublethal or lethal doses of LQQ venom, centrally or peripher-
ally, exhibited dose-dependent pathological changes in hearts,
lungs, kidneys and livers, summarized in Table 3 and represen-
tatives shown in Fig. 8B, D, F and H.
As shown in Table 3, pretreatment with lidocaine, 30 min
before venom, greatly protected envenomed rabbits from the
venom-evoked pathological manifestations with the only
changes seen being focal necrosis in myocardium, focal haem-
orrhagic patches in lung and slight congestion in renal convo-
luted tubules and hepatic sinusoids.
4. Discussion
In the present study, peripheral or central injection, of suble-
thal or lethal doses of venom from the Old World LQQ scor-
pion into conscious rabbits, lead to multiple organ dysfunction
(with sublethal doses)/failure (lethal doses). This was evident
from alterations in cardiac output, estimated hepatic blood
ﬂow, abnormalities in cardiac, hepatic, renal and/or pancreatic
biomarkers. Additionally, lethal doses of the venom, whether
central or peripheral led to hypertension, terminal hypoten-
sion, pulmonary edema, multiple organ failure and death.
Most signs and symptoms of scorpion envenomation have
been attributed to action of venom neurotoxins mainly on
Na+ channels and the resultant exaggerated release of various
neurotransmitters and mediators, ultimately leading to multi-
ple organ dysfunction/failure, as seen in this study, with death
in fatal cases usually due to cardiorespiratory failure (Fatani
et al., 1998, 2000, 2010; Fukuhara et al., 2003; Abdoon
et al., 2006).
In this study peripheral injection of the venom, whether s.c.
or i.v, usually resulted in analogous manifestations. Toxicoki-netic studies of scorpions venoms including LQQ, measuring
plasma 125I-labeled venom (Ismail et al., 1992; Caldero´n-Aran-
da et al., 1999) or toxin concentrations by ELISA (Revelo
et al., 1996; Kriﬁ et al., 2005), showed rapid distribution
half-lives ranging from less than 1 min after i.v up to 7 min fol-
lowing s.c injections in rabbits, guinea-pigs or rats.
Symptoms of scorpion envenomation in humans and exper-
imental animals also include neurological manifestations, espe-
cially in the younger and older age groups, including: local
pain, paresthesia, hyperaesthesia, restlessness, increased re-
ﬂexes, tremors and/or convulsions. In animals, as was ob-
served in this study, convulsion-related symptoms encompass
wet dog shakes, staring, masticatory jaw movements, facial
automatisms, orofacial movements, blinking, twitching and/
or shivering. Moreover, scorpion venom elicits autonomic
overstimulation, manifesting as abdominal pain, vomiting,
excessive sweating, salivation, diaphoresis, hyperglycemia,
hyperamylasemia, cold extremities, hypo-/hyperpnea, pulmon-
ary edema, tachy-/brady-arrhythmias, hyper- and/or hypoten-
sion (Ismail, 1995; Bosnak et al., 2009; Guidine et al., 2009;
Nencioni et al., 2009). In this study, peripheral or central injec-
tion of LQQ venom into conscious rabbits (to avoid the mask-
ing effects of anaesthesia) lead to the characteristic systemic
manifestations, in addition to symptoms of over-stimulation
of autonomic nervous system and CNS excitation.
Despite clear neurological involvement, it is difﬁcult to as-
sess if scorpion neurotoxicity is restricted to peripheral actions
or if a central mechanism may be partly responsible for sys-
temic manifestations. Central effects of scorpion venom toxins
have been somehow neglected, with the belief that these pep-
tides do not cross the blood–brain barrier (BBB) (Ismail
et al., 1992; Revelo et al., 1996). During the last decade
Clot-Faybesse et al. (2000) and Nunan et al. (2003) detected
scorpion venom in the CNS after its systemic administration
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Figure 8 Representative histopathological changes observed in hearts (A and B), lungs (C and D), kidneys (E and F) and livers (G and
H) following the injection of 0.9% NaCl (A, C, E and G; 2 ll kg1, i.c.v.) or LQQ venom (B, D, F and H; 3 lg kg1, i.c.v.) (100 and 200·).
Representative pictures are shown: (A) Normal myocardium; (B) myocardium with interstitial haemorrhage and focal necrosis; (C)
normally appearing pulmonary alveoli and bronchioles in the lung; (D) diffuse haemorrhage and focal atelectatic areas of collapse in the
lung; (E) normally appearing glomerulus and renal convoluted tubules of kidney; (F) kidneys with congested blood vessels, diffuse
haemorrhage and cloudy swelling; (G) normal liver tissue; (H) marked diffuse fatty changes in hepatocytes and focal haemorrhagic areas.
148 A.J. Fataniinto newborn rodents with under developed BBB, with the lat-
ter suggesting that higher plasma levels of toxin would increase
the probability of small quantities gaining access to the CNS.
In this study peripheral injection of sublethal or lethal
quantities of LQQ venom lead to MOD or MOF and neuro-
logical signs and symptoms, comparable to that seen when
equivalent micro amounts (about 100 times less) were injected
i.c.v. into conscious rabbits (albeit neurological symptomswere more intense in the latter case). This would favour the
hypothesis that both peripheral actions and leakage into the
CNS could play a role in central and systemic manifestations
observed following scorpion envenomation. The results of this
study are in agreement with investigators who showed that
i.c.v. injection of minute amounts of the New World scorpion
tityustoxin led to both central and cardio-respiratory manifes-
tations (Carvalho et al., 1998). It is possible that the venom
Table 3 Histopathological changes in selected organs of male adult rabbits injected with LQQ scorpion venom by different routes
alone or 30 min after pretreatment with lidocaine.
A Heart Lung
Group Haemorrhage Necrosis Interstitial
reactions
Haemorrhage Congestion/edema Emphysema/collapse
0.9% NaCl (0.2 ml kg1 s.c., iv; 2 ll kg1, i.c.v.) _ _ _ _ _ _
LQQ (0.2 mg kg1 s.c.) + + – + + –
LQQ (0.5 mg kg1 i.v.) +++ ++ + ++ ++ +
LQQ (2 ug kg1 i.c.v.) + + – + + –
LQQ (3 ug kg1 i.c.v.) +++ ++ + +++ +++ +
Lidocaine iv + LQQ (3 ug kg1 i.c.v.) – + – + – –
Lidocaine iv + LQQ (0.5 mg kg1 i.v.) – + – – – –
B Kidney Liver
Group Cloudy
swelling
Focal
inﬂammatn
Congestn Hydropic
degeneratn
Portal
inﬂammatn
Congestion Fatty
changes
0.9% NaCl (0.2 ml kg1 s.c., i.v.; 2 ll kg1, i.c.v.) – – – – – – –
LQQ (0.2 mg kg1 s.c.) + – + - + – +
LQQ (0.5 mg kg1 i.v.) ++ + ++ + ++ ++ ++
LQQ (2 ug kg1 i.c.v.) + – + – + – +
LQQ (3 ug kg1 i.c.v.) ++ + ++ + ++ ++ ++
Lidocaine i.v. + LQQ (3 ug kg1 i.c.v.) – – + – – + –
Lidocaine i.v. + LQQ (0.5 mg kg1 i.v.) – – – – – + –
Changes were compiled and averaged from ﬁve male adult rabbits per group. In pre-treatment groups, lidocaine (1 mg kg1 i.v. bolus
initially, followed by i.v. infusion of 50 lg kg1 min1 at a rate of 4.5 ml h1) was administered 30 min before lethal dose of venom (i.c.v. or
i.v.). Organs were ﬁxed in 10% formalin, stained with Hematoxylin and Eosin. (): no change; (+): mild change; (++): moderate change;
(+++): marked change.
Comparative study between peripherally and centrally acting sublethal and lethal 149may pass through BBB via the 4th ventricle (naturally more
permeable), compromising the control function exerted by car-
diovascular/respiratory nuclei and the bulbar neural substrates
(Stober et al., 1988). On the other hand, Mesquita et al. (2003)
demonstrated that peripherally-injected tityustoxin, unlike the
present study, did not reproduce comparable effects to that ob-
served after i.c.v. injection. Discrepancy with this study may be
due to different methodology or variability between New (b)
and Old World (a) Scorpion toxins (Kopeyan et al., 2006).
Mesquita et al. (2003) concluded that the CNS can solely ac-
count for systemic manifestations observed in their study fol-
lowing i.c.v. tityustoxin injection.
Additional postulations to venom neurotoxin-evoked cen-
tral/peripheral relationship include: (a) central action and sub-
sequent stimulation of catecholamine release in the periphery
(Lima and Freire-Maia, 1977) or (b) retrograde circulation
of toxin, from ventricular to venous systems through absorp-
tion at the level of the arachnoidal granulations, favouring di-
rect peripheral action for centrally injected toxin (Drumond
et al., 1995).
Most symptoms and signs observed in scorpion envenoma-
tion have been attributed to the effects of the scorpion venom
neurotoxins on Na+ channels and the exaggerated release of
neurotransmitters and mediators. These include GABA, dopa-
mine, glycine, serotonin, and glutamate (Dorce and Sandoval,
1994; Ismail, 1995) which are known to generate and/or prop-
agate seizures and may explain the venom-elicited convulsion-
related symptoms (Chai et al., 2007). A diversity of modula-
tors/mediators are also released by scorpion venom neurotox-
ins, such as kinins, prostaglandins, cytokines, interleukins and
TNF-a. Several have play a role in venom-evoked inﬂamma-
tory responses leading to non-cardiogenic pulmonary edema,acute respiratory distress syndrome, complement system acti-
vation, leucocytosis, systemic inﬂammatory response syn-
drome, and ultimately multiple organ dysfunction/failure
(Barraviera, 1997; Fatani et al., 1998; Fukuhara et al., 2003;
Abdoon and Fatani, 2009).
It is clear that venom-evoked Na+ channel activation is the
ﬁrst step in the cascade of events that take place after scorpion
envenomation and several studies have demonstrated its efﬁ-
cacy in protecting animals from peripherally injected scorpion
venom (Fatani et al., 2000, 2010; Vital et al., 2002; Al-Shanaw-
ani et al., 2005). Moreover, several investigators have shown
that several a neurotoxins, including those present in LQQ ve-
nom, have higher afﬁnity for peripheral sodium channels than
for those of the central nervous system (Hamon et al., 2002;
Kopeyan et al., 2006). Therefore this study attempted to deter-
mine whether lidocaine, could also ameliorate lethal systemic
manifestations resulting from central administration of the ve-
nom. Pretreatment of rabbits with lidocaine greatly attenuated
terminal hypotension, pulmonary edema, pathological changes
in the heart, lung, liver plus kidney, and prolonged survival in
animals injected with lethal doses of LQQ venom whether
peripherally or centrally.
It is apparent that the actions of venom toxins are multi-
faceted resulting in both central and peripheral pathological
manifestations. Lidocaine proved effective in ameliorating
MOF resulting from either peripheral or central injection of
LQQ venom. This highlights that regardless of route, binding
of scorpion toxins to Na+ channels, and the resultant exagger-
ated depolarization plus cascade of mediators released, plays
an important role in following central or systemic administra-
tion of venom, culminating in lethal cases in MOF and death.
This study also showed the plausibility that leakage through an
150 A.J. Fataniunderdeveloped or compromised BBB, may explain the en-
hanced CNS manifestations seen in children and elderly, In
both cases, blocking the ﬁrst step of the cascade with a Na+
channel blocker may be more beneﬁcial than treating the after-
math symptomatically or attempting to block the multitude of
neurotransmitters and modulators released by the venom.
Although this work promotes a better understanding of the
interconnectivity of venom actions centrally and peripherally,
and the potential beneﬁts of lidocaine, nevertheless, more stud-
ies in this ﬁeld are imperative to further determine the exact
mechanisms involvedReferences
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